Aedifica NV/SA: Interim financial report - Q3 2026


Please find below Aedifica’s interim financial report for the 3rd quarter of the 2026 financial year.

Creating Europe’s leading healthcare REIT 

  • Following a legal merger by absorption on 1 July 2026, Aedifica owns 100% of the shares in Cofinimmo, resulting in the delisting of Cofinimmo from Euronext 
  • A new Board of Directors and Executive Committee were appointed earlier this year, and the integration process is well on track 
  • With legal merger completed, expected synergies will accelerate further, reaching full run-rate impact of at least €16 million during 2027 

Robust operational performance driving strong results1 

  • EPRA Earnings* per share increased to €4.12 (+5% compared to 30 Sept. 2025), highlighting the accretiveness of the Cofinimmo transaction 
  • EPRA Earnings* amounted to €320.0 million (+72% compared to 30 Sept. 2025) 
  • Rental income increased to €476.7 million (+75% compared to 30 Sept. 2025) 
  • 2.0% increase in rental income on a like-for-like basis* in the first 9 months of the year2 
  • Weighted average unexpired lease term of 15 years and occupancy rate of 99.2% 

Real estate portfolio* of €12.6 billion as at 30 September 2026 

  • Healthcare portfolio of €11.2 billion: 930 properties for nearly 81,000 end users across 9 countries 
  • Valuation of investment properties remained slightly positive in Q3 (+0.1%) and increased by 0.4% YTD on a like-for-like basis 
  • €124 million of new investments in Q3, bringing the investment total to €217 million YTD (15 new projects added to pipeline & 3 acquisitions) 
  • 27 projects totalling €249 million have been completed so far in 2026 
  • Investment programme of €560 million as at 30 Sept. 2026 

Solid balance sheet and strong liquidity 

  • Moody’s assigned Aedifica an A3 investment-grade credit rating with stable outlook 
  • Sustainability bond issuance of €500 million, strengthening liquidity and extending average debt maturity 
  • 42.1% debt-to-assets ratio as at 30 September 2026 (compared to 40.8% on 31 Dec. 2025) 
  • €1,540 million of headroom on committed credit lines to finance CAPEX and liquidity needs 
  • €985 million contracted in new long-term bank financing as at 30 September 2026 
  • Average cost of debt* including commitment and utilisation fees of 1.9% 
  • EPRA NTA* of €79.19/share (vs. €78.40/share on 31 December 2025, before distribution of the dividend) 

Outlook for 2026 reaffirmed 

  • EPRA Earnings* for 2026 are estimated at €436 million, or €5.35/share 
  • Proposed dividend for the 2026 financial year: €4.20/share (gross), increasing by 5%

Attachments



Pièces jointes

Press release EN Persbericht NL Communiqué de presse FR
GlobeNewswire